Values as of: 2024-11-03
COMMON STOCK | Health Information Services |
Last Closing
USD 9Change
0.00 (0.00)%Market Cap
USD 0.14BVolume
0.04MAnalyst Target
N/AVerdict
Verdict
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts. Address: 75 State Street, Boston, MA, United States, 02109
Company Website : https://business.amwell.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| SOLV | Solventum Corp. |
N/A |
USD 10.78B |
| DOCS | Doximity Inc |
N/A |
USD 7.80B |
| WEAV | Weave Communications Inc |
N/A |
USD 1.02B |
| MPLN | MultiPlan Corporation |
N/A |
USD 0.14B |
| OWLT | Owlet Inc |
N/A |
USD 0.08B |
| PHR | Phreesia Inc |
N/A |
N/A |
| VEEV | Veeva Systems Inc Class A |
N/A |
N/A |
| FOXO | FOXO Technologies Inc. |
N/A |
N/A |
| EVH | Evolent Health Inc |
N/A |
N/A |
| TDOC | Teladoc Inc |
N/A |
N/A |
N/A
| Market Performance vs. Industry/Classification (Health Information Services) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 504.03% | 80% | B- | 96% | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 504.03% | 80% | B- | 96% | N/A | ||
| Trailing 12 Months | |||||||
| Capital Gain | 533.80% | 90% | A- | 96% | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 533.80% | 90% | A- | 96% | N/A | ||
| Trailing 5 Years | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -19.10% | 40% | F | 3% | F | ||
| Dividend Return | -19.10% | 40% | F | 2% | F | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 257.30% | 20% | F | 4% | F | ||
| Risk Adjusted Return | -7.42% | 50% | F | 18% | F | ||
| Market Capitalization | 0.14B | 33% | F | 32% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
This stock has shown below median revenue growth in the previous 5 years compared to its sector
